anderson cancer center

(American Association for Cancer Research) People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at higher risk of developing lung cancer than those with effective genomic repair capability, according to researchers from the department of epidemiology at the University of Texas M.

D. Anderson Cancer Center.

(University of Texas M. D. Anderson Cancer Center) Metformin, the common first-line drug for type 2 diabetes, may be effective in increasing pathologic complete response rates in diabetic women with early stage breast cancer who took the drug during chemotherapy prior to having surgery, paving the way for further research of the drug as a potential cancer therapy, according to researchers at the University of Texas M.

D. Anderson Cancer Center.

(University of Texas M. D. Anderson Cancer Center) A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a US phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston.

(University of Texas M. D. Anderson Cancer Center) Efforts to protect the tumor-suppressor p53 could just as easily shelter a mutant version of the protein, causing cancer cells to thrive and spread rather than die, according to research by scientists at the University of Texas M.

D. Anderson Cancer Center reported in the current issue of the journal Genes and Development.

(University of Texas M. D. Anderson Cancer Center) A poster session presented today by the University of Texas M.

D. Anderson Cancer Center at the Oncology Nurses Society 33rd Annual Congress, found that early nursing intervention and implementation of effective strategies can lead to a decrease in the incidence of lymphedema, better management of chronic lymphedema and improved quality of life in breast cancer patients.

(University of Texas M. D. Anderson Cancer Center) Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer, also known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer, according to a Phase II clinical trial led by researchers at The University of Texas M.

D. Anderson Cancer Center.

(University of Texas M. D. Anderson Cancer Center) Researchers from The University of Texas M. D. Anderson Cancer Center have found a therapy that effectively kills human leukemia cells in mice using natural killer cells from umbilical cord blood.

(University of Texas M. D. Anderson Cancer Center) According to nurse-researchers at the University of Texas M. D.

Anderson Cancer Center in Houston, participation among nurses in the institution's unique Professional Action Coordinating Teams has increased 50 percent in one year.

(University of Texas M. D. Anderson Cancer Center) Researchers from the University of Texas M. D. Anderson Cancer Center have found a possible approach to therapy that may make cancer cells more sensitive to attack by immune system cells while making the immune system cells more powerful.

(University of Texas M. D. Anderson Cancer Center) In an effort to better define and ultimately address fatigue more effectively, a qualitative study from The University of Texas M.

D. Anderson Cancer Center has identified three primary themes-- loss of strength or energy, major effects of fatigue and associated sensations -- among patients being treated with standard radiation therapy.